{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:21:05Z","timestamp":1773375665989,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5977,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.nurt.2007.02.001","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T07:19:14Z","timestamp":1175066354000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Genotype-Phenotype Correlation and Therapeutic Rationale in Hyperkalemic Periodic Paralysis"],"prefix":"10.1016","volume":"4","author":[{"given":"Karin","family":"Jurkat-Rott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lehmann-Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2007.02.001_bib1","first-page":"1257","article-title":"Nondystrophic myotonias and periodic paralyses","volume":"Vol. 2","author":"Lehmann-Horn","year":"2004"},{"key":"10.1016\/j.nurt.2007.02.001_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/mus.880121103","article-title":"Adynamia episodica hereditaria: what causes the weakness?","volume":"12","author":"Ricker","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.02.001_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneur.1990.00530090091018","article-title":"Progressive myopathy in hyperkalemic periodic paralysis","volume":"47","author":"Bradley","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2007.02.001_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0960-8966(93)90009-9","article-title":"Non-dystrophic myotonias and periodic paralyses","volume":"3","author":"Lehmann-Horn","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2007.02.001_bib5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/WNL.35.8.1208","article-title":"Potentially fatal cardiac dysrhythmia and hyperkalemic periodic paralysis","volume":"35","author":"Gould","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.22.8.810","article-title":"Hyperkalemic periodic paralysis and cardiac arrhythmia","volume":"22","author":"Lisak","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00442678","article-title":"Periodic paralysis with cardiac arrhythmia","volume":"140","author":"Yoshimura","year":"1983","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.nurt.2007.02.001_bib8","unstructured":"Jurkat-Rott K, Lehmann-Horn F. Hyperkalemic periodic paralysis type I. Gene Reviews at GeneTests 2005; Available at: http:\/\/www.genetests.org, Medical Genetics Information Resource [database online]. Funded by NIH. Copyright, University of Washington, Seattle."},{"key":"10.1016\/j.nurt.2007.02.001_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1092-148","article-title":"Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel","volume":"2","author":"McClatchey","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2007.02.001_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.49.4.1018","article-title":"A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity","volume":"49","author":"Wagner","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.22.3.269","article-title":"Periodic muscle weakness, normokalemia, and tubular aggregates","volume":"22","author":"Meyers","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0002-9343(61)90122-X","article-title":"A third type of periodic paralysis with normokalemia and favorable response to sodium chloride","volume":"31","author":"Poskanzer","year":"1961","journal-title":"Am J Med"},{"key":"10.1016\/j.nurt.2007.02.001_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10257","article-title":"Normokalemic periodic paralysis revisited: does it exist?","volume":"52","author":"Chinnery","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.02.001_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/01.WNL.0000145768.09934.EC","article-title":"New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis","volume":"63","author":"Vicart","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","article-title":"Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene","volume":"250","author":"Fontaine","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.02.001_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/354387a0","article-title":"A Met-to-Val mutation in the skeletal muscle sodium channel \u03b1-subunit in hyperkalemic periodic paralysis","volume":"354","author":"Rojas","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.02.001_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.58.8.1266","article-title":"Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5","volume":"58","author":"Bendahhou","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0022-510X(96)00173-6","article-title":"Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene","volume":"142","author":"Plassart","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2007.02.001_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(91)90374-8","article-title":"Identification of a mutation in the gene causing hyperkalemic periodic paralysis","volume":"67","author":"Ptacek","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.02.001_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s004150170059","article-title":"Hyperkalemic periodic paralysis and paramyotonia congenita: a novel sodium channel mutation","volume":"248","author":"Okuda","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2007.02.001_bib21","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1523\/JNEUROSCI.19-12-04762.1999","article-title":"Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation","volume":"19","author":"Bendahhou","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.02.001_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI9654","article-title":"A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation","volume":"106","author":"Bendahhou","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.02.001_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00370530","article-title":"Altered gating and conductance of Na+ channels in hyperkalemic periodic paralysis","volume":"418","author":"Lehmann-Horn","year":"1991","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.nurt.2007.02.001_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.880100414","article-title":"Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH","volume":"10","author":"Lehmann-Horn","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.02.001_bib25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1212\/01.wnl.0000233841.75824.0f","article-title":"Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness","volume":"67","author":"Weber","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1152\/physrev.1999.79.4.1317","article-title":"Voltage-gated ion channels and hereditary disease","volume":"79","author":"Lehmann-Horn","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nurt.2007.02.001_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0006-3495(94)80807-0","article-title":"Slow Na+ channel inactivation must be disrupted to evoke prolonged depolarization-induced paralysis","volume":"66","author":"Ruff","year":"1994","journal-title":"Biophys J"},{"key":"10.1016\/j.nurt.2007.02.001_bib28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0006-3495(97)78768-X","article-title":"Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis","volume":"72","author":"Hayward","year":"1997","journal-title":"Biophys J"},{"key":"10.1016\/j.nurt.2007.02.001_bib29","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1212\/WNL.54.11.2191","article-title":"Defective slow inactivation of sodium channels contributes to familial periodic paralysis","volume":"54","author":"Ruff","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/mus.880100709","article-title":"Membrane defects in paramyotonia congenita (Eulenburg)","volume":"10","author":"Lehmann-Horn","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.02.001_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0960-8966(96)00429-4","article-title":"Paramyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel \u03b1 subunit: a large kindred with a novel phenotype","volume":"7","author":"Kelly","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2007.02.001_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp.70.5.618","article-title":"Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica","volume":"70","author":"Kim","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.02.001_bib33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/jnnp.74.9.1339","article-title":"Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A","volume":"74","author":"Brancati","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.02.001_bib34","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.33.12.1615","article-title":"Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis","volume":"33","author":"Ricker","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib35","series-title":"Structural and molecular basis of skeletal muscle diseases","first-page":"95","article-title":"Diseases associated with ion channel and ion transporter defects: dyskalemic episodic weakness","author":"Jurkat-Rott","year":"2002"},{"key":"10.1016\/j.nurt.2007.02.001_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/bja\/72.2.210","article-title":"Anaesthesia and myotonia","volume":"72","author":"Russell","year":"1994","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nurt.2007.02.001_bib37","first-page":"426","article-title":"Dyskalemic periodic paralysis and myotonia","volume":"76","author":"Neuman","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nurt.2007.02.001_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","article-title":"Complications of anaesthesia in neuromuscular disorders","volume":"15","author":"Klingler","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nurt.2007.02.001_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1096\/fj.03-0722fje","article-title":"Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats","volume":"18","author":"Tricarico","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.nurt.2007.02.001_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen\u2019s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features","volume":"35","author":"Tawil","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.02.001_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/342360","article-title":"KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes","volume":"71","author":"Andelfinger","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2007.02.001_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.02.001_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2019s syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.02.001_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-2828(03)00046-4","article-title":"Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen\u2019s syndrome","volume":"35","author":"Hosaka","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nurt.2007.02.001_bib45","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen\u2013Tawil syndrome patients with KCNJ2 mutations: characteristic T-U\u2013wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nurt.2007.02.001_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0092-8674(01)00207-0","article-title":"MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis","volume":"104","author":"Abbott","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.02.001_bib47","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/01.WNL.0000119392.29624.88","article-title":"Periodic paralysis mutation MiRP2-R83H in controls: interpretations and general recommendation","volume":"62","author":"Jurkat-Rott","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/01.WNL.0000082392.66713.E3","article-title":"Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis","volume":"61","author":"Sternberg","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.02.001_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1092-144","article-title":"Periodic paralysis in quarter horses: a sodium channel mutation disseminated by selective breeding","volume":"2","author":"Rudolph","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2007.02.001_bib50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2460\/javma.1990.197.08.1009","article-title":"Hyperkalemic periodic paralysis in horses","volume":"197","author":"Spier","year":"1990","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.nurt.2007.02.001_bib51","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/3.9.1599","article-title":"Pathophysiology of sodium channelopathies: correlation of normal\/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis","volume":"3","author":"Zhou","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2007.02.001_bib52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2460\/javma.1996.209.04.798","article-title":"Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis","volume":"209","author":"Carr","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.nurt.2007.02.001_bib53","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1152\/jn.1995.73.5.1892","article-title":"Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis","volume":"73","author":"Cannon","year":"1995","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.nurt.2007.02.001_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1113\/jphysiol.1996.sp021773","article-title":"The equine periodic paralysis Na+ channel mutation alters molecular transitions between the open and inactivated states","volume":"497","author":"Hanna","year":"1996","journal-title":"J Physiol"},{"key":"10.1016\/j.nurt.2007.02.001_bib55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1993.sp019731","article-title":"Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis","volume":"466","author":"Cannon","year":"1993","journal-title":"J Physiol"},{"key":"10.1016\/j.nurt.2007.02.001_bib56","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0006-3495(93)81045-2","article-title":"Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels","volume":"65","author":"Cannon","year":"1993","journal-title":"Biophys J"},{"key":"10.1016\/j.nurt.2007.02.001_bib57","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI25525","article-title":"Muscle channelopathies and critical points in functional and genetic studies","volume":"115","author":"Jurkat-Rott","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.02.001_bib58","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1212\/WNL.57.10.1849","article-title":"Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative","volume":"57","author":"Desaphy","year":"2001","journal-title":"Neurology"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2007.02.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:39:44Z","timestamp":1761806384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923006700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1878747923006700"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2007.02.001","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-Phenotype Correlation and Therapeutic Rationale in Hyperkalemic Periodic Paralysis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2007.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}